Sark Bio-Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 2 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
About Sark Bio-Sciences
Sark Bio-Sciences Private Limited (SBPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 June 2022 (Two years and seven months 28 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Allada Sirisha, Mohammed Hussen, Vamshi Modem, and One other member serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24290TG2022PTC164141
- Company No.
164141
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jun 2022
- Date of AGM
13 Nov 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Sark Bio-Sciences?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Allada Sirisha  | Director | 27-Jun-2022 | Current |
| Mohammed Hussen | Director | 27-Jun-2022 | Current |
| Vamshi Modem | Director | 27-Jun-2022 | Current |
| Ranga Bopparaju | Director | 27-Jun-2022 | Current |
Financial Performance of Sark Bio-Sciences.
Sark Bio-Sciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sark Bio-Sciences?
Unlock access to Sark Bio-Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Shreetanu Pharma Chem India Private LimitedRanga Bopparaju is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sark Bio-Sciences?
Sark Bio-Sciences has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sark Bio-Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sark Bio-Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.